PHARMAKON A/S — Credit Rating and Financial Key Figures
Credit rating
Company information
About PHARMAKON A/S
PHARMAKON A/S (CVR number: 10038839) is a company from HILLERØD. The company reported a net sales of 140.5 mDKK in 2023, demonstrating a growth of 9 % compared to the previous year. The operating profit percentage was at 3.3 % (EBIT: 4.7 mDKK), while net earnings were 5100 kDKK. The profitability of the company measured by Return on Assets (ROA) was 5.3 %, which can be considered decent and Return on Equity (ROE) was 5.2 %, which can be considered decent. The equity ratio, a key indicator for solidity, stood at 81.6 %, a level that can be considered to be very good, which means that the majority of assets are financed by equity. PHARMAKON A/S's liquidity measured by quick ratio was 3.6 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsNet sales (mDKK)
EBIT (mDKK)
Profitability
Solidity
Key figures (mDKK)
See financials2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | 117.06 | 128.94 | 140.53 | ||
Gross profit | 91.86 | 91.19 | 95.45 | ||
EBIT | 2.45 | 2.79 | 10.06 | 2.79 | 4.71 |
Net earnings | 1.92 | 2.40 | 8.26 | 2.73 | 5.10 |
Shareholders equity total | 81.47 | 83.87 | 92.13 | 94.86 | 99.97 |
Balance sheet total (assets) | 114.59 | 124.14 | 125.44 | 126.88 | 126.49 |
Net debt | -8.11 | -2.36 | -6.55 | ||
Profitability | |||||
EBIT-% | 8.6 % | 2.2 % | 3.3 % | ||
ROA | 2.1 % | 2.3 % | 8.7 % | 3.0 % | 5.3 % |
ROE | 2.4 % | 2.9 % | 9.4 % | 2.9 % | 5.2 % |
ROI | 2.7 % | 2.9 % | 11.1 % | 3.7 % | 6.4 % |
Economic value added (EVA) | -2.09 | -1.92 | 3.63 | -1.65 | -0.58 |
Solvency | |||||
Equity ratio | 71.1 % | 67.6 % | 77.2 % | 80.0 % | 81.6 % |
Gearing | 0.0 % | 0.0 % | 0.0 % | ||
Relative net indebtedness % | 15.2 % | 17.4 % | 9.2 % | ||
Liquidity | |||||
Quick ratio | 1.4 | 1.8 | 2.5 | 3.2 | 3.6 |
Current ratio | 1.4 | 1.8 | 1.9 | 2.1 | 2.9 |
Cash and cash equivalents | 8.15 | 2.40 | 6.56 | ||
Capital use efficiency | |||||
Trade debtors turnover (days) | 35.7 | 32.2 | 34.2 | ||
Net working capital % | 19.5 % | 22.1 % | 26.0 % | ||
Credit risk | |||||
Credit rating | A | AA | AAA | AAA | AA |
Variable visualization
Roles
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions

... and more!
No registration needed.